Department of Epidemiology, School of Public Health and Tropical Medicine, Tulane University, New Orleans, Louisiana.
Departamento de Laboratorio Clínico, Hospital Escuela, Tegucigalpa, Honduras.
Am J Trop Med Hyg. 2024 Jun 4;111(1):64-72. doi: 10.4269/ajtmh.23-0493. Print 2024 Jul 3.
We aimed to measure the association between Trypanosoma cruzi infection in pregnancy and reduced fetal growth in the absence of T. cruzi congenital transmission. We conducted a cross-sectional study of secondary data of all singleton live births between 2011 and 2013 in five hospitals from Argentina, Honduras, and Mexico. We excluded newborns with T. cruzi infection. Noninfected pregnant people were those without any positive rapid tests. The main study outcomes were birth weight, head circumference, and length for gestational age and sex. Logistic regression models were adjusted for country, age, education level, and obstetric history. Of the 26,544 deliveries, 459 (1.7%) pregnant people were found by rapid tests to be positive for T. cruzi. Of these, 320 were positive by enzyme-linked immunosorbent assay and 231 had a positive polymerase chain reaction (PCR) test. Uninfected newborns from T. cruzi-infected pregnant people were more likely to have birth weights below the 5th and 10th percentiles and head circumferences below the 3rd and 10th percentiles. Among T. cruzi-infected pregnant people diagnosed by PCR, the odds ratios were 1.58 for birth weight below the 10th percentile (95% CI, 1.12-2.23) and 1.57 for birth weight below the 5th percentile (95% CI, 1.02-2.42). Higher T. cruzi parasitic loads in pregnancy had a stronger association with reduced fetal growth (both in birth weight and head circumference), with an odds ratio of 2.31 (95% CI, 1.36-3.91) for a birth weight below the 5th percentile. The association shows, irrespective of causality, that newborns of pregnancies with T. cruzi have an increased risk of reduced fetal growth. We recommend further studies to assess other potential confounders and the causality of these associations.
我们旨在衡量妊娠期感染克氏锥虫与无克氏锥虫先天性传播的情况下胎儿生长受限之间的关联。我们对来自阿根廷、洪都拉斯和墨西哥的五家医院 2011 年至 2013 年间所有单胎活产儿的二级数据进行了横断面研究。我们排除了感染克氏锥虫的新生儿。未感染的孕妇是指没有任何快速检测阳性的孕妇。主要研究结果是出生体重、头围和性别与胎龄的关系。逻辑回归模型调整了国家、年龄、教育水平和产科史。在 26544 例分娩中,459 例(1.7%)孕妇快速检测克氏锥虫阳性。其中 320 例酶联免疫吸附试验阳性,231 例聚合酶链反应(PCR)试验阳性。来自克氏锥虫感染孕妇的未感染新生儿更有可能体重低于第 5 和第 10 百分位,头围低于第 3 和第 10 百分位。在通过 PCR 诊断为克氏锥虫感染的孕妇中,体重低于第 10 百分位的比值比为 1.58(95%可信区间,1.12-2.23),体重低于第 5 百分位的比值比为 1.57(95%可信区间,1.02-2.42)。妊娠期间克氏锥虫寄生虫载量越高,与胎儿生长受限的关联越强(体重和头围均如此),体重低于第 5 百分位的比值比为 2.31(95%可信区间,1.36-3.91)。这些关联表明,无论因果关系如何,克氏锥虫感染孕妇的新生儿发生胎儿生长受限的风险增加。我们建议进一步研究以评估其他潜在混杂因素和这些关联的因果关系。
Cochrane Database Syst Rev. 2022-5-20
Evid Rep Technol Assess (Full Rep). 2009-3
Cochrane Database Syst Rev. 2018-8-20
Cochrane Database Syst Rev. 2022-11-17
Am J Obstet Gynecol. 2015-10-9
Cochrane Database Syst Rev. 2011-7-6
Cochrane Database Syst Rev. 2022-7-22
Cochrane Database Syst Rev. 2010-3-17
Front Immunol. 2020
Am J Obstet Gynecol. 2018-2